secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K/A
Filed at:   2023-12-14T23:59:59+00:00
Accession:  0001628280-23-041578
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beauty Health finalizes separation with former CEO Stanleick; 58,536 shares vested, 18-month non-compete
--------------------------------------------------------------------------------

- CEO Andrew Stanleick terminated without cause effective Nov 19, 2023; signed Separation Letter on Dec 8, 2023.
- Severance includes 18 months base salary, prorated target bonus, COBRA reimbursements, and outplacement up to $15,000.
- Retention award of 58,536 shares of Class A common stock fully vested within 15 days of signing release.
- 18-month non-competition covenant barring work with microdermabrasion/hydrodermabrasion machine manufacturers.
- Mutual non-disparagement agreed; Stanleick remains bound by existing confidentiality obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828023041578/0001628280-23-041578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828023041578/skin-20231110.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-041578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer